Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.

Proteins and peptides are increasingly important therapeutics for the treatment of severe and complex diseases like cancer or autoimmune diseases due to their high specificity and potency. Their unique structure and labile physicochemical properties, however, require special attention in the production and formulation process as well as during administration. Aside from conventional systemic injections, the topical application of proteins and peptides is an appealing alternative due to its non-invasive nature and thus high acceptance by patients. For this approach, soft matter nanocarriers are interesting delivery systems which offer beneficial properties such as high biocompatibility, easiness of modifications, as well as targeted drug delivery and release. This review aims to highlight and discuss technological developments in the field of soft matter nanocarriers for the delivery of proteins and peptides via the skin, the eye, the nose, and the lung, and to provide insights in advantages, limitations, and practicability of recent advances.

[1]  Xiuli Wang,et al.  Solid lipid nanoparticles for pulmonary delivery of insulin. , 2008, International journal of pharmaceutics.

[2]  B. Sarmento,et al.  Nanocarriers for pulmonary administration of peptides and therapeutic proteins. , 2011, Nanomedicine.

[3]  Ching-Hua Wang,et al.  Pulmonary delivery of insulin by liposomal carriers. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. Hanes,et al.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.

[5]  N. Di Girolamo,et al.  Vitronectin: a migration and wound healing factor for human corneal epithelial cells. , 2014, Investigative ophthalmology & visual science.

[6]  K. Taylor,et al.  The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants. , 2009, International journal of pharmaceutics.

[7]  Claus-Michael Lehr,et al.  Modeling the human skin barrier--towards a better understanding of dermal absorption. , 2013, Advanced drug delivery reviews.

[8]  Vivek T. Natarajan,et al.  Multifaceted pathways protect human skin from UV radiation. , 2014, Nature chemical biology.

[9]  U. Kompella,et al.  Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab. , 2013, Molecular pharmaceutics.

[10]  J. Reichrath,et al.  Quantification of nanoparticle uptake into hair follicles in pig ear and human forearm. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Qiang Zhang,et al.  Development of a pulmonary peptide delivery system using porous nanoparticle-aggregate particles for systemic application. , 2013, International journal of pharmaceutics.

[12]  Eva Roblegg,et al.  Mucus as barrier for drug delivery by nanoparticles. , 2014, Journal of nanoscience and nanotechnology.

[13]  Hanns-Christian Mahler,et al.  Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.

[14]  M. Naash,et al.  Drug and gene delivery to the back of the eye: from bench to bedside. , 2014, Investigative ophthalmology & visual science.

[15]  P. Rigby,et al.  Preliminary studies on the development of IgA-loaded chitosan–dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens , 2013, Journal of microencapsulation.

[16]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[17]  A. Yamamoto,et al.  Absorption Enhancement of Intrapulmonary Administered Insulin by Various Absorption Enhancers and Protease Inhibitors in Rats , 1994, The Journal of pharmacy and pharmacology.

[18]  Y. Kawashima,et al.  Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  C. Musabayane,et al.  Transdermal Delivery of Insulin by Amidated Pectin Hydrogel Matrix Patch in Streptozotocin-Induced Diabetic Rats: Effects on Some Selected Metabolic Parameters , 2014, PloS one.

[20]  F. Bérard,et al.  Allergen penetration through the skin. , 2003, European journal of dermatology : EJD.

[21]  Jyothi U. Menon,et al.  Polymeric nanoparticles for pulmonary protein and DNA delivery. , 2014, Acta biomaterialia.

[22]  C. Remuñán-López,et al.  Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  Michael C Veronesi,et al.  Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles , 2009, Neurotherapeutics.

[24]  W. Friess,et al.  Optimization of the Fine Particle Fraction of a Lyophilized Lysozyme Formulation for Dry Powder Inhalation , 2013, Pharmaceutical Research.

[25]  D. Wirtz,et al.  Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus , 2004, Biotechnology progress.

[26]  V. Torchilin,et al.  Current trends in the use of liposomes for tumor targeting. , 2013, Nanomedicine.

[27]  M. Alonso,et al.  Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat. , 1998, Current eye research.

[28]  M. Naud,et al.  New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[29]  W. Kreyling,et al.  The influence of pulmonary surfactant on nanoparticulate drug delivery systems. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  K. Wiesmüller,et al.  Topical vaccination with functionalized particles targeting dendritic cells. , 2013, The Journal of investigative dermatology.

[31]  H. Takeuchi,et al.  Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  M. Naud,et al.  Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats , 2007, Molecular vision.

[33]  J. Arias Liposomes in drug delivery: a patent review (2007 – present) , 2013, Expert opinion on therapeutic patents.

[34]  R. Vanbever,et al.  Crucial Biopharmaceutical Issues Facing Macromolecular Candidates for Inhalation: The Role of Macrophages in Pulmonary Protein Clearance , 2007 .

[35]  Vladimir Kral,et al.  Therapeutic application of peptides and proteins: parenteral forever? , 2009, Trends in biotechnology.

[36]  C. Dass,et al.  Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery , 2010, Peptides.

[37]  N. Nishiyama,et al.  Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm. , 2009, Angewandte Chemie.

[38]  A. Misra,et al.  A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: A technical note , 2005, AAPS PharmSciTech.

[39]  C. Selomulya,et al.  The effects of engineered nanoparticles on pulmonary immune homeostasis , 2014, Drug metabolism reviews.

[40]  M. Foldvari,et al.  Evidence for lymphatic transport of insulin by topically applied biphasic vesicles , 2003, The Journal of pharmacy and pharmacology.

[41]  R. Gurny,et al.  Cyclosporine A delivery to the eye: a pharmaceutical challenge. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[42]  F. Blank,et al.  Opportunities and challenges of the pulmonary route for vaccination , 2011, Expert opinion on drug delivery.

[43]  M. Prausnitz,et al.  Delivery of salmon calcitonin using a microneedle patch. , 2012, International journal of pharmaceutics.

[44]  V. Torchilin,et al.  Polymer-Modified Liposomes: From Long-Circulating to Multifunctional , 2014 .

[45]  V. Walle,et al.  Peptide and protein delivery , 2011 .

[46]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[47]  H. Flynn,et al.  Drug delivery techniques for treating age-related macular degeneration , 2014, Expert opinion on drug delivery.

[48]  S J Prestrelski,et al.  Biopharmaceutical powders: particle formation and formulation considerations. , 2000, Current pharmaceutical biotechnology.

[49]  A. Sintov,et al.  Topical iodine facilitates transdermal delivery of insulin. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[50]  M. L. La Rotonda,et al.  Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies. , 2014, Advanced drug delivery reviews.

[51]  P. Diwan,et al.  Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery , 2007, Journal of drug targeting.

[52]  M. Calderón,et al.  Thermosensitive nanogels based on dendritic polyglycerol and N-isopropylacrylamide for biomedical applications , 2011 .

[53]  Mizuo Maeda,et al.  pH-responsive release of proteins from biocompatible and biodegradable reverse polymer micelles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[54]  Sanjay K. Jain,et al.  Peptide and protein delivery using new drug delivery systems. , 2013, Critical reviews in therapeutic drug carrier systems.

[55]  C. Remuñán-López,et al.  Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[56]  Wei Wang,et al.  Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.

[57]  Haripriya Kalluri,et al.  Transdermal Delivery of Proteins , 2011, AAPS PharmSciTech.

[58]  R. Gurny,et al.  Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[59]  Shulin Ding RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .

[60]  Emanuel Fleige,et al.  Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. , 2012, Advanced drug delivery reviews.

[61]  X. Chen,et al.  Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo , 2011, International journal of nanomedicine.

[62]  W. Seeger,et al.  Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[63]  L. Illum Nasal drug delivery--possibilities, problems and solutions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[64]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[65]  G. P. Martin,et al.  Transdermal drug delivery systems: skin perturbation devices. , 2008, Methods in molecular biology.

[66]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[67]  A. Urtti,et al.  Current and future ophthalmic drug delivery systems. A shift to the posterior segment. , 2008, Drug discovery today.

[68]  Claus-Michael Lehr,et al.  The Interplay of Lung Surfactant Proteins and Lipids Assimilates the Macrophage Clearance of Nanoparticles , 2012, PloS one.

[69]  A. Almeida,et al.  Solid lipid nanoparticles as a drug delivery system for peptides and proteins. , 2007, Advanced drug delivery reviews.

[70]  J. McGrath,et al.  Anatomy and Organization of Human Skin , 2008 .

[71]  Aleksander S Popel,et al.  Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth. , 2012, Translational oncology.

[72]  Yi-you Huang,et al.  Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization. , 2013, Acta biomaterialia.

[73]  C. Kitson,et al.  Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium , 2001, Gene Therapy.

[74]  J. Nguyen,et al.  Biodegradable polymeric nanocarriers for pulmonary drug delivery. , 2008, Expert opinion on drug delivery.

[75]  Subhash Chandra Yadav,et al.  Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation , 2011, Peptides.

[76]  J. Wolchok,et al.  Antibody therapy of cancer , 2012, Nature Reviews Cancer.

[77]  Huibi Xu,et al.  Enhanced Nasal Mucosal Delivery and Immunogenicity of Anti-Caries DNA Vaccine through Incorporation of Anionic Liposomes in Chitosan/DNA Complexes , 2013, PloS one.

[78]  B. Malaekeh-Nikouei,et al.  PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION , 2009, Retina.

[79]  T. Seki,et al.  Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[80]  S. Smedt,et al.  Cystic fibrosis sputum: a barrier to the transport of nanospheres. , 2000, American journal of respiratory and critical care medicine.

[81]  J. Patton,et al.  The lungs as a portal of entry for systemic drug delivery. , 2004, Proceedings of the American Thoracic Society.

[82]  A. Hickey,et al.  Liposomal dry powders as aerosols for pulmonary delivery of proteins , 2005, AAPS PharmSciTech.

[83]  Juliane Nguyen,et al.  Biodegradable polymeric nanocarriers for pulmonary drug delivery , 2008 .

[84]  P. Uzor,et al.  Perspectives on Transdermal Drug Delivery , 2011 .

[85]  L. Reid,et al.  Bronchial mucus in health and disease. , 1978, British medical bulletin.

[86]  T. Ebensen,et al.  Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization. , 2013, Vaccine.

[87]  Qiang Zhang,et al.  Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. , 2001, International journal of pharmaceutics.

[88]  C. Wood,et al.  Therapeutic peptides: technological advances driving peptides into development. , 2006, Current opinion in biotechnology.

[89]  Gary P. Martin,et al.  Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects , 2006, Drug delivery.

[90]  G. Lagoumintzis,et al.  Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses. , 2010, International journal of pharmaceutics.

[91]  H. Takeuchi,et al.  Surface modification of liposomes using polymer-wheat germ agglutinin conjugates to improve the absorption of peptide drugs by pulmonary administration. , 2013, Journal of pharmaceutical sciences.

[92]  G. Borchard,et al.  Lectin-Functionalized Liposomes for Pulmonary Drug Delivery: Interaction with Human Alveolar Epithelial Cells , 2001, Journal of drug targeting.

[93]  A. Cattaneo,et al.  Intranasal delivery of therapeutic proteins for neurological diseases , 2011, Expert opinion on drug delivery.

[94]  C. Barnstable,et al.  A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres. , 2006, Experimental eye research.

[95]  R. Löbenberg,et al.  Targeted delivery of nanoparticles for the treatment of lung diseases. , 2008, Advanced drug delivery reviews.

[96]  Xin-guo Jiang,et al.  Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease. , 2014, International journal of pharmaceutics.

[97]  M. Foldvari Biphasic vesicles: a novel topical drug delivery system. , 2010, Journal of biomedical nanotechnology.

[98]  E. Fattal,et al.  Liposomes for intravitreal drug delivery: a state of the art. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[99]  R. Gurny,et al.  Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. , 2011, International journal of pharmaceutics.

[100]  C. Lehr,et al.  Transfollicular delivery takes root: the future for vaccine design? , 2014, Expert review of vaccines.

[101]  H F Edelhauser,et al.  Drug delivery for posterior segment eye disease. , 2000, Investigative ophthalmology & visual science.

[102]  G. Menon,et al.  International Journal of Pharmaceutics , 2012 .

[103]  R. Neubert,et al.  Dermal Peptide Delivery Using Enhancer Molecules and Colloidal Carrier Systems – Part I: Carnosine , 2012, Skin Pharmacology and Physiology.

[104]  T. Ebensen,et al.  Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[105]  S. Mangal,et al.  Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[106]  F. Rinaldi,et al.  Pulmonary Delivery: Innovative Approaches and Perspectives , 2011 .

[107]  Qun Wang,et al.  Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. , 2008, Journal of drug targeting.

[108]  Feroz Jameel,et al.  Formulation and process development strategies for manufacturing biopharmaceuticals , 2010 .

[109]  V. Préat,et al.  Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs. , 2004, Journal of pharmaceutical sciences.

[110]  B. Khoobehi,et al.  Liposome-bound cyclosporine: Aqueous and vitreous level after subconjunctival injection , 2004, International Ophthalmology.

[111]  B. Khoobehi,et al.  Liposome-bound cyclosporine: Clearance after intravitreal injection , 2004, International Ophthalmology.

[112]  F. Gu,et al.  Development of mucoadhesive drug delivery system using phenylboronic acid functionalized poly(D,L-lactide)-b-dextran nanoparticles. , 2012, Macromolecular bioscience.

[113]  Ying-zheng Zhao,et al.  Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy , 2012, Acta Diabetologica.

[114]  G. A. Hofmann,et al.  Transdermal iontophoretic delivery of salmon calcitonin. , 2000, International journal of pharmaceutics.

[115]  Saurabh Aggarwal,et al.  What's fueling the biotech engine? , 2007, Nature Biotechnology.

[116]  C. Berkland,et al.  Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. , 2012, Cancer research.

[117]  Mei-Chin Chen,et al.  Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats. , 2013, Acta biomaterialia.

[118]  R. B. Campbell,et al.  Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations. , 2010, Journal of pharmaceutical sciences.

[119]  Shohei Sugimoto,et al.  Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[120]  M. del Río,et al.  Topical enzyme-replacement therapy restores transglutaminase 1 activity and corrects architecture of transglutaminase-1-deficient skin grafts. , 2013, American journal of human genetics.

[121]  G. Winter,et al.  Protein stability in pulmonary drug delivery via nebulization. , 2015, Advanced drug delivery reviews.

[122]  Robert N. Weinreb,et al.  Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma , 2012, Nature Reviews Drug Discovery.

[123]  Lei Sun,et al.  Amphiphilic glycopolymer nanoparticles as vehicles for nasal delivery of peptides and proteins. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[124]  Bruce K Rubin,et al.  Emerging aerosol drug delivery strategies: from bench to clinic. , 2014, Advanced drug delivery reviews.

[125]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[126]  J. Mitchell,et al.  Recombinant filaggrin is internalized and processed to correct filaggrin deficiency. , 2014, The Journal of investigative dermatology.

[127]  C. Chiang,et al.  Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[128]  Michael S. Roberts,et al.  Modeling the human skin barrier--towards a better understanding of dermal absorption. , 2013, Advanced drug delivery reviews.

[129]  M. Foldvari,et al.  In vivo sustained dermal delivery and pharmacokinetics of interferon alpha in biphasic vesicles after topical application. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[130]  J. Manosroi,et al.  Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide , 2013, Drug development and industrial pharmacy.

[131]  Priyanka Ghosh,et al.  Challenges and opportunities in dermal/transdermal delivery. , 2010, Therapeutic delivery.

[132]  T. Kissel,et al.  Controlled pulmonary drug and gene delivery using polymeric nano-carriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[133]  Xinge Zhang,et al.  Mucoadhesive and enzymatic inhibitory nanoparticles for transnasal insulin delivery. , 2014, Nanomedicine.

[134]  Saurabh Aggarwal,et al.  What's fueling the biotech engine—2012 to 2013 , 2014, Nature Biotechnology.

[135]  T. Minko,et al.  Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA , 2011, Journal of drug targeting.

[136]  Daniel E. Otzen,et al.  Protein drug stability: a formulation challenge , 2005, Nature Reviews Drug Discovery.

[137]  Costas Kiparissides,et al.  Recent advances in nanocarrier-based mucosal delivery of biomolecules. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[138]  G. Peyman,et al.  Applications of liposomes in ophthalmology. , 2005, Survey of ophthalmology.

[139]  A. Turner,et al.  Personalizing medicine for metastatic colorectal cancer: current developments. , 2014, World journal of gastroenterology.

[140]  B. Bloom,et al.  Immunization by a bacterial aerosol , 2008, Proceedings of the National Academy of Sciences.

[141]  L. Babiuk,et al.  Vaccine delivery: lipid-based delivery systems. , 2000, Journal of biotechnology.

[142]  R. Prassl,et al.  Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery. , 2007, Biochimica et biophysica acta.

[143]  H. Katinger,et al.  Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs. , 2008, Journal of aerosol medicine and pulmonary drug delivery.

[144]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[145]  Emmanouil D Karagiannis,et al.  A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells , 2008, Proceedings of the National Academy of Sciences.

[146]  H. Kohno,et al.  Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats. , 2007, Investigative ophthalmology & visual science.

[147]  P. Wertz,et al.  Current Understanding of Skin Biology Pertinent to Skin Penetration: Skin Biochemistry , 2013, Skin Pharmacology and Physiology.

[148]  C. Haynes,et al.  Topical delivery of interferon alpha by biphasic vesicles: evidence for a novel nanopathway across the stratum corneum. , 2010, Molecular pharmaceutics.

[149]  B. Freeman,et al.  Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. , 1995, The American journal of physiology.

[150]  F. Nestle,et al.  Mechanisms regulating skin immunity and inflammation , 2014, Nature Reviews Immunology.

[151]  M. Khoshayand,et al.  The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[152]  Samir Mitragotri,et al.  Multifunctional nanoparticles for drug delivery and molecular imaging. , 2013, Annual review of biomedical engineering.

[153]  S. Cryan,et al.  Carrier-based strategies for targeting protein and peptide drugs to the lungs , 2005, The AAPS Journal.

[154]  M. Goosen,et al.  Transdermal delivery of peptide and protein drugs: An overview , 1995 .

[155]  P. Anderson,et al.  Interleukin-2 liposomes for primary immune deficiency using the aerosol route. , 2002, International immunopharmacology.

[156]  J. Cherng,et al.  ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES , 2001, Journal of liposome research.

[157]  Nevin Celebi,et al.  Controlled delivery of peptides and proteins. , 2007, Current pharmaceutical design.

[158]  V. Préat,et al.  Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[159]  P. Campochiaro,et al.  Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide. , 2013, Biomaterials.

[160]  P. Anderson,et al.  Interleukin‐2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases , 1997, Cancer.

[161]  I. Rico-Lattes,et al.  Drug delivery by soft matter: matrix and vesicular carriers. , 2009, Angewandte Chemie.

[162]  S. Bale,et al.  Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris , 2006, Nature Genetics.

[163]  Hans P Merkle,et al.  Formulation aspects of biodegradable polymeric microspheres for antigen delivery. , 2005, Advanced drug delivery reviews.

[164]  P. Beuzeboc,et al.  Targeting HER2 in other tumor types. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[165]  Maria Palmira Daflon Gremião,et al.  Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. , 2006, Current drug delivery.

[166]  Praveen Kumar,et al.  Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats. , 2002, Diabetes technology & therapeutics.

[167]  B. Luppi,et al.  Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles , 2010, Expert opinion on drug delivery.

[168]  Daniela Traini,et al.  Magnetised Thermo Responsive Lipid Vehicles for Targeted and Controlled Lung Drug Delivery , 2012, Pharmaceutical Research.

[169]  R. Vanbever,et al.  Delivery strategies for sustained drug release in the lungs. , 2014, Advanced drug delivery reviews.

[170]  H. Takeuchi,et al.  Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[171]  Eun Seong Lee,et al.  Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes , 2013, International journal of nanomedicine.

[172]  T. Gardner,et al.  Retinal angiogenesis in development and disease , 2005, Nature.

[173]  R. Juliano Challenges to macromolecular drug delivery. , 2007, Biochemical Society transactions.

[174]  Desirée Teijeiro-Osorio,et al.  New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. , 2009, Biomacromolecules.

[175]  R. Vanbever,et al.  Peptides and Proteins: Pulmonary Absorption , 2013 .

[176]  H. Cui,et al.  Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[177]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[178]  B. Shekunov,et al.  Lipid-based carriers for pulmonary products: preclinical development and case studies in humans. , 2014, Advanced drug delivery reviews.

[179]  H. Junginger,et al.  Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. , 2009, Vaccine.

[180]  R. Hancock,et al.  In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide. , 2001, Journal of pharmaceutical sciences.

[181]  Theodore W Randolph,et al.  Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release. , 2012, Journal of pharmaceutical sciences.

[182]  Zhen Gu,et al.  Stimuli-responsive nanomaterials for therapeutic protein delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[183]  Clive G. Wilson,et al.  Topical and systemic drug delivery to the posterior segments. , 2005, Advanced drug delivery reviews.

[184]  Gary M Pollack,et al.  Nasal drug administration: potential for targeted central nervous system delivery. , 2005, Journal of pharmaceutical sciences.

[185]  L. Kowalczuk,et al.  Protein delivery for retinal diseases: From basic considerations to clinical applications , 2010, Progress in Retinal and Eye Research.

[186]  Wei Yang,et al.  Inhaled nanoparticles--a current review. , 2008, International journal of pharmaceutics.

[187]  Shri Kant,et al.  Polymeric nanoparticulate system: a potential approach for ocular drug delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[188]  Tushar K. Vyas,et al.  Intranasal drug delivery for brain targeting. , 2005, Current drug delivery.

[189]  W. Hennink,et al.  Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. , 2003, International journal of pharmaceutics.

[190]  D. Morck,et al.  Treatment of corneal defects with delayed re‐epithelization with a medical device/drug delivery system for epidermal growth factor , 2012, Clinical & experimental ophthalmology.

[191]  J. Pastor,et al.  Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A , 1996, Pharmaceutical Research.